What is the recommended dose of cephalexin (cephalexin) for an adult patient with mild to moderate bacterial infection and normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin 500 mg Dosing for Adults

For adults with mild to moderate bacterial infections and normal renal function, the standard dose of cephalexin is 500 mg every 6 hours (four times daily), with a total daily dose ranging from 1 to 4 grams depending on infection severity. 1

Standard Dosing Regimens

The FDA-approved dosing for cephalexin is 250 mg every 6 hours for routine infections, with 500 mg every 6 hours recommended for more severe infections or less susceptible organisms. 1 The Infectious Diseases Society of America specifically recommends 500 mg four times daily for skin and soft tissue infections caused by methicillin-susceptible Staphylococcus aureus (MSSA). 2, 3

Alternative Dosing for Specific Infections

  • For uncomplicated cystitis, streptococcal pharyngitis, and uncomplicated skin infections: 500 mg every 12 hours (twice daily) is FDA-approved for patients over 15 years of age, with treatment duration of 7-14 days for cystitis. 1

  • For urinary tract infections: Recent evidence demonstrates that 500 mg twice daily is as effective as four-times-daily dosing, with no difference in treatment failure rates (12.7% vs 17%, P=0.343) and potentially improved adherence. 4

Infection-Specific Considerations

Skin and Soft Tissue Infections

Cephalexin 500 mg four times daily provides excellent coverage against MSSA and streptococcal species. 2, 3 However, critical pitfalls exist:

  • Do not use cephalexin if MRSA is suspected - it has zero activity against methicillin-resistant organisms. Switch to trimethoprim-sulfamethoxazole, doxycycline, or clindamycin instead. 3

  • Cephalexin has poor anaerobic coverage - avoid for deep abscesses or infections likely involving anaerobes. 2

  • Limited activity against Pasteurella multocida and Eikenella corrodens - not ideal for animal or human bite wounds without combination therapy. 2

Respiratory Tract Infections

Cephalexin should NOT be used for acute bacterial sinusitis or many respiratory infections due to poor coverage of Haemophilus influenzae and Moraxella catarrhalis. 2 It is completely ineffective against Pseudomonas aeruginosa. 2

Streptococcal Pharyngitis

For streptococcal pharyngitis, cephalexin must be administered for at least 10 days to prevent rheumatic fever, regardless of symptom resolution. 1, 2

When to Escalate Therapy

If daily doses exceeding 4 grams are required, switch to parenteral cephalosporins (e.g., cefazolin 1 g IV every 8 hours) rather than increasing oral cephalexin beyond FDA-approved limits. 1, 2

Dosing Schedule for Optimal Adherence

Four-times-daily dosing should be spaced every 6 hours (e.g., 6:00 AM, 12:00 PM, 6:00 PM, 12:00 AM) to maintain consistent antibiotic levels. 2 For infections where twice-daily dosing is appropriate, spacing doses 12 hours apart improves adherence without compromising efficacy. 4, 5

Renal Dose Adjustment

Patients with creatinine clearance less than 30 mL/min require dose reduction proportional to their reduced renal function, as 70-100% of cephalexin is renally excreted unchanged within 6-8 hours. 6

Allergy Considerations

Cephalexin can be used in patients with non-severe penicillin allergy (e.g., delayed rash), but is contraindicated in those with immediate hypersensitivity reactions such as anaphylaxis, angioedema, or urticaria to penicillins due to potential cross-reactivity. 3

References

Guideline

Cephalexin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cephalexin Dosing for Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.